C83.1A
Mantle cell lymphoma, in remission
Clinical Classification Guidelines
Inclusion Terms
- Centrocytic lymphoma, in remission
Medical Intelligence & Overview
Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma that originates from B-cells in the lymphatic system. When it is described as being 'in remission,' it indicates that signs and symptoms of the disease have significantly decreased or disappeared following treatment. The ICD-10 code C83.1A specifically refers to cases where this cancer is currently in remission following previous therapy. Historically, mantle cell lymphoma was sometimes classified under centrocytic lymphoma, but modern classifications distinguish it separately, though terminology might still be encountered in older literature or notes.
Causes & Symptoms
Clinical Causes: Genetic mutations in B-cell lymphocytes Overexpression of the cyclin D1 gene due to chromosome translocation (t(11;14)) Age-related changes, most common in older adults Potential environmental exposures, though specific environmental causes are not well-established Family history of lymphomas or other blood cancers
Key Symptoms: Swollen lymph nodes, often painless Unexplained weight loss Persistent fever and night sweats Fatigue or weakness Abdominal pain or swelling from enlarged spleen or lymph nodes Frequent infections due to immune system compromise Signs of gastrointestinal involvement such as nausea or abdominal discomfort
Diagnostic & Treatment
Diagnosis Path: Diagnosis of mantle cell lymphoma in remission involves several steps:
Treatment Protocols: While a patient is in remission, ongoing care involves monitoring and sometimes maintenance therapy, depending on individual circumstances. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C83.1A a billable ICD-10 code?
Yes, C83.1A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.1A?
Clinical documentation must specify the nature of Mantle cell lymphoma, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference